tiprankstipranks
Trending News
More News >
Erasca (ERAS)
NASDAQ:ERAS
US Market

Erasca (ERAS) Stock Investors

Compare
264 Followers
Based on 800,570 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ERAS
On average, investors allocate 0.00% of their portfolios to ERAS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 800,570 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ERAS

2.7%
Last 7
Days
1.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ERAS, out of 800,570 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ERAS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
3.73%
$1.47
Based on the activity of investors who made their portfolios public
The table shows changes in ERAS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ERAS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.75%
-1.30%
-4.40%
3.11B
Healthcare
Lucid Group
5.34%
+0.30%
-1.50%
8.11B
Consumer Cyclical
DraftKings
4.36%
+0.21%
+2.46%
31.01B
Consumer Cyclical
JD
4.51%
-1.33%
-1.01%
53.24B
Consumer Cyclical
Recursion Pharmaceuticals
3.14%
-2.08%
-6.51%
1.68B
Healthcare
Zscaler
3.57%
+0.28%
-1.34%
39.12B
Technology
Marathon Digital Holdings
4.95%
-1.95%
-3.77%
5.51B
Financial
Riot Platforms
4.49%
-1.80%
-1.93%
3.19B
Financial
CVS Health
4.03%
-0.33%
-1.64%
80.63B
Healthcare
Nio
8.36%
-2.09%
-4.54%
8.12B
Consumer Cyclical
Based on the activity of 800,570 active portfolios
Open your Smart Portfolio

ERAS Investor Analysis

ERAS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.6%
of ERAS holders
are under 35
Average Segment Performance
Average P/E Ratio11.76
Beta4.25
Dividend Yield4.06%
ERAS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
43.8%
of ERAS holders
are between 35–55
Average Segment Performance
Average P/E Ratio6.19
Beta11.21
Dividend Yield3.42%
ERAS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.6%
of ERAS holders
are over 55
Average Segment Performance
Average P/E Ratio1.75
Beta6.30
Dividend Yield3.69%
Overview of age group and performance of ERAS stock investors
See who invests in ERAS according to age group and performance.

FAQ

How many retail Investors hold ERAS?
<0.1% of TipRanks' retail investors hold ERAS in their portfolios.
    What is ERAS Investor Sentiment?
    ERAS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ERAS in the last 7 days?
      ▼ 2.7% of TipRanks' retail investors changed their holding of ERAS in the last 7 days.
        What percentage of retail investors changed their holding of ERAS in the last 30 days?
        ▼ 1.0% of TipRanks' retail investors changed their holding of ERAS in the last 30 days.
          What is the average age of retail investors who hold ERAS?
          The average age of ERAS Holders is between 35–55.
            What other stocks have ERAS investors also bought?
            ERAS Investors also bought VKTX, LCID, DKNG, JD, RXRX, ZS, MARA, RIOT, CVS, NIO.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis